Wearing masks helps us keep each other safe. Masks are required in our facilities.
If you cannot wear a mask, contact your care team before you visit to discuss telehealth. Patients and visitors not wearing masks will not be permitted to enter.
Cancer Types & Treatments
NCI CANCER CENTER
Patients & Caregivers
Becoming Our Patient
Cancer Education
Tools & Resources
For Caregivers
Support Services
Survivorship & Hope
Clinical Trials
Find a Clinical Trial
Reasons to Participate
How to Join a Clinical Trial
For Professionals & Partners
Research
Areas of Research
Research Programs
Research That Transforms
Give Back to Research
Training & Education
Faculty Development
Graduate Education
Fellowship & Residency
High School & Undergraduate
Outreach & Prevention
Outreach & Community Initiatives
Prevention & Risk Reduction
Cancer Awareness
Researchers at The University of Kansas Cancer Center have received a three-year, $900,000 grant from the Ovarian Cancer Research Alliance (OCRA) to better understand why epithelial ovarian cancers take decades to develop as well as identify methods...
Triple-negative breast cancer is unique because it lacks estrogen receptors, progesterone receptors and excess HER2 protein – the drivers of other breast cancer subtypes. It is more aggressive and has a poorer prognosis, primarily because there are f...
A preclinical study led by researchers at The University of Kansas Cancer Center has identified a potential new target in the treatment of pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer. Their findings were published in G...
Andrew Godwin, PhD, deputy director of The University of Kansas Cancer Center and professor and director of Molecular Oncology in the department of Pathology and Laboratory Medicine at the University of Kansas Medical Center, has been awarded a Higuc...
The International Society of Gastrointestinal Oncology (ISGIO), a not-for-profit global educational organization committed to gastrointestinal oncology, announced that Weijing Sun, MD, FACP, has been elected the society’s next leader. Dr. Sun serves...
First patient enrolled at The University of Kansas Cancer Center in expansion cohort study characterizing the safety, pharmacokinetics and pharmacodynamics of fosciclopirox in bladder cancer patients. Kansas City, MO – December 4, 2019 – CicloMed LLC...
Each year, The University of Kansas Cancer Center hosts its Research Symposium, convening experts to collaborate and discuss advances in cancer research. As part of Research Symposium activities, members and partners of the cancer center are recogniz...
In recognition of a significant contribution made by the Kansas Masons to support efforts to prevent cancer and improve people's lives, the Midwest Cancer Alliance is now the Masonic Cancer Alliance. The name change from Midwest Cancer Alliance to Ma...
A $60,000 grant from the Ovarian Cancer Research Alliance (OCRA) will help launch a novel peer-to-peer mentoring program at The University of Kansas Cancer Center for women diagnosed with gynecologic cancers. The support program, called Woman to Woma...
Priyanka Sharma, MD, breast oncologist at The University of Kansas Cancer Center, was awarded a $100,000 grant from The Mary Kay Foundation to advance research efforts on targeted therapy for metastatic breast cancer. Despite clinical advances, 40,00...
Researchers at The University of Kansas Cancer Center have identified an agent that improves risk biomarkers for breast cancer while reducing menopausal side effects in women at increased risk for breast cancer. Chemoprevention drugs like tamoxifen c...
Ronald Chen, MD, MPH, has been named the Brandmeyer Chair and Professor of Radiation Oncology at the University of Kansas School of Medicine, clinical service chief at The University of Kansas Health System and associate director for Health Equity at...
Kim Jones, a member of The University of Kansas Cancer Center’s Patient and Investigator Voices Organizing Together (PIVOT) program, has been named a Komen Advocate in Science (AIS). After being diagnosed with breast cancer in 2012, Jones devoted her...
The University of Kansas Cancer Center and Midwest Cancer Alliance have been awarded a grant to expand the reach of cancer clinical trials to Kansas’ rural communities. The six-year grant designates the team as a minority/underserved (MU) community s...
While people in rural areas across the U.S. are less likely than urban dwellers to be diagnosed with cancer, they are more likely to die from it. A multidisciplinary team of researchers from The University of Kansas Cancer Center has received a five-...